Form PRE 14A TScan Therapeutics, Inc. For: Nov 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) | Delayed: 0.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.19 | 52 Week High | $26.80 | |||
| Open | $0.19 | 52 Week Low | $23.00 | |||
| Day High | $0.19 | P/E | N/A | |||
| Day Low | $0.19 | EPS | $0.00 | |||
| Volume | 20,968 | |||||
